What it is used for
KIOVIG administered intravenously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
(2) Immunomodulation indications
- Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;
- Guillain Barre syndrome;
- Kawasaki Disease.
- Multifocal Motor Neuropathy
KIOVIG administered subcutaneously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
KIOVIG administered intravenously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
(2) Immunomodulation indications
- Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;
- Guillain Barre syndrome;
- Kawasaki Disease.
- Multifocal Motor Neuropathy
KIOVIG administered subcutaneously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Print the CMI.
Listen to the CMI.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
KIOVIG administered intravenously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
(2) Immunomodulation indications
- Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;
- Guillain Barre syndrome;
- Kawasaki Disease.
- Multifocal Motor Neuropathy
KIOVIG administered subcutaneously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
KIOVIG administered intravenously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
(2) Immunomodulation indications
- Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;
- Guillain Barre syndrome;
- Kawasaki Disease.
- Multifocal Motor Neuropathy
KIOVIG administered subcutaneously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
What it is used for
KIOVIG administered intravenously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
- Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
(2) Immunomodulation indications
- Idiopathic thrombocytopenia purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count;
- Guillain Barre syndrome;
- Kawasaki Disease.
- Multifocal Motor Neuropathy
KIOVIG administered subcutaneously is indicated for:
(1) Replacement therapy indications
- Primary immunodeficiency disorders (PID);
How to take it
The way to take this medicine is: Intravenous.
This medicine or fluids is given through a needle or tube (catheter) inserted into a vein.
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
The solution should be relatively clear with a slight opalescense.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
